Figure 1|Potential mechanisms underlying DNLA-mediated neuroprotection in Alzheimer’s disease (AD) models.
Nutraceuticals have become promising new compounds to prevent or treat AD. As reported, substantial preclinical studies indicate that DNLA is a promising molecule to counteract various pathophysiological processes of AD, thereby improving cognitive functions and inhibiting neurodegeneration. As shown in Figure 1.